FTC Approves Sublicense for Synacthen Depot Submitted by Mallinckrodt ARD Inc. (MNK)
The Federal Trade Commission has approved a sublicense submitted by Mallinckrodt ARD Inc. (NYSE: MNK) granting West Therapeutic Development, LLC ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
